[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Soft Tissue Biologics Market, Global Outlook and Forecast 2022-2028

June 2022 | 74 pages | ID: S7A00A806AC8EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Soft Tissue Biologics in global, including the following market information:

Global Soft Tissue Biologics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Soft Tissue Biologics Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Soft Tissue Biologics companies in 2021 (%)

The global Soft Tissue Biologics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Carpal Soft Tissue Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Soft Tissue Biologics include AlloSource, Arthrex, ConMed, LifeNet Health, Smith & Nephew, Stryker, Surgalign Spine Technologies and Zimmer Biomet, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Soft Tissue Biologics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Soft Tissue Biologics Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Soft Tissue Biologics Market Segment Percentages, by Type, 2021 (%)
  • Carpal Soft Tissue
  • Cubital Soft Tissue
  • Plantar Fascia Soft Tissue
  • Gastrocnemius Mollis Soft Tissue
  • Tarsal Tunnel Soft Tissue
  • Others
Global Soft Tissue Biologics Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Soft Tissue Biologics Market Segment Percentages, by Application, 2021 (%)
  • General Hospitals
  • Speciality Clinics
  • Others
Global Soft Tissue Biologics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Soft Tissue Biologics Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Soft Tissue Biologics revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Soft Tissue Biologics revenues share in global market, 2021 (%)

Key companies Soft Tissue Biologics sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Soft Tissue Biologics sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • AlloSource
  • Arthrex
  • ConMed
  • LifeNet Health
  • Smith & Nephew
  • Stryker
  • Surgalign Spine Technologies
  • Zimmer Biomet
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Soft Tissue Biologics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Soft Tissue Biologics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL SOFT TISSUE BIOLOGICS OVERALL MARKET SIZE

2.1 Global Soft Tissue Biologics Market Size: 2021 VS 2028
2.2 Global Soft Tissue Biologics Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Soft Tissue Biologics Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Soft Tissue Biologics Players in Global Market
3.2 Top Global Soft Tissue Biologics Companies Ranked by Revenue
3.3 Global Soft Tissue Biologics Revenue by Companies
3.4 Global Soft Tissue Biologics Sales by Companies
3.5 Global Soft Tissue Biologics Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Soft Tissue Biologics Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Soft Tissue Biologics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Soft Tissue Biologics Players in Global Market
  3.8.1 List of Global Tier 1 Soft Tissue Biologics Companies
  3.8.2 List of Global Tier 2 and Tier 3 Soft Tissue Biologics Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Soft Tissue Biologics Market Size Markets, 2021 & 2028
  4.1.2 Carpal Soft Tissue
  4.1.3 Cubital Soft Tissue
  4.1.4 Plantar Fascia Soft Tissue
  4.1.5 Gastrocnemius Mollis Soft Tissue
  4.1.6 Tarsal Tunnel Soft Tissue
  4.1.7 Others
4.2 By Type - Global Soft Tissue Biologics Revenue & Forecasts
  4.2.1 By Type - Global Soft Tissue Biologics Revenue, 2017-2022
  4.2.2 By Type - Global Soft Tissue Biologics Revenue, 2023-2028
  4.2.3 By Type - Global Soft Tissue Biologics Revenue Market Share, 2017-2028
4.3 By Type - Global Soft Tissue Biologics Sales & Forecasts
  4.3.1 By Type - Global Soft Tissue Biologics Sales, 2017-2022
  4.3.2 By Type - Global Soft Tissue Biologics Sales, 2023-2028
  4.3.3 By Type - Global Soft Tissue Biologics Sales Market Share, 2017-2028
4.4 By Type - Global Soft Tissue Biologics Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Soft Tissue Biologics Market Size, 2021 & 2028
  5.1.2 General Hospitals
  5.1.3 Speciality Clinics
  5.1.4 Others
5.2 By Application - Global Soft Tissue Biologics Revenue & Forecasts
  5.2.1 By Application - Global Soft Tissue Biologics Revenue, 2017-2022
  5.2.2 By Application - Global Soft Tissue Biologics Revenue, 2023-2028
  5.2.3 By Application - Global Soft Tissue Biologics Revenue Market Share, 2017-2028
5.3 By Application - Global Soft Tissue Biologics Sales & Forecasts
  5.3.1 By Application - Global Soft Tissue Biologics Sales, 2017-2022
  5.3.2 By Application - Global Soft Tissue Biologics Sales, 2023-2028
  5.3.3 By Application - Global Soft Tissue Biologics Sales Market Share, 2017-2028
5.4 By Application - Global Soft Tissue Biologics Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Soft Tissue Biologics Market Size, 2021 & 2028
6.2 By Region - Global Soft Tissue Biologics Revenue & Forecasts
  6.2.1 By Region - Global Soft Tissue Biologics Revenue, 2017-2022
  6.2.2 By Region - Global Soft Tissue Biologics Revenue, 2023-2028
  6.2.3 By Region - Global Soft Tissue Biologics Revenue Market Share, 2017-2028
6.3 By Region - Global Soft Tissue Biologics Sales & Forecasts
  6.3.1 By Region - Global Soft Tissue Biologics Sales, 2017-2022
  6.3.2 By Region - Global Soft Tissue Biologics Sales, 2023-2028
  6.3.3 By Region - Global Soft Tissue Biologics Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Soft Tissue Biologics Revenue, 2017-2028
  6.4.2 By Country - North America Soft Tissue Biologics Sales, 2017-2028
  6.4.3 US Soft Tissue Biologics Market Size, 2017-2028
  6.4.4 Canada Soft Tissue Biologics Market Size, 2017-2028
  6.4.5 Mexico Soft Tissue Biologics Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Soft Tissue Biologics Revenue, 2017-2028
  6.5.2 By Country - Europe Soft Tissue Biologics Sales, 2017-2028
  6.5.3 Germany Soft Tissue Biologics Market Size, 2017-2028
  6.5.4 France Soft Tissue Biologics Market Size, 2017-2028
  6.5.5 U.K. Soft Tissue Biologics Market Size, 2017-2028
  6.5.6 Italy Soft Tissue Biologics Market Size, 2017-2028
  6.5.7 Russia Soft Tissue Biologics Market Size, 2017-2028
  6.5.8 Nordic Countries Soft Tissue Biologics Market Size, 2017-2028
  6.5.9 Benelux Soft Tissue Biologics Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Soft Tissue Biologics Revenue, 2017-2028
  6.6.2 By Region - Asia Soft Tissue Biologics Sales, 2017-2028
  6.6.3 China Soft Tissue Biologics Market Size, 2017-2028
  6.6.4 Japan Soft Tissue Biologics Market Size, 2017-2028
  6.6.5 South Korea Soft Tissue Biologics Market Size, 2017-2028
  6.6.6 Southeast Asia Soft Tissue Biologics Market Size, 2017-2028
  6.6.7 India Soft Tissue Biologics Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Soft Tissue Biologics Revenue, 2017-2028
  6.7.2 By Country - South America Soft Tissue Biologics Sales, 2017-2028
  6.7.3 Brazil Soft Tissue Biologics Market Size, 2017-2028
  6.7.4 Argentina Soft Tissue Biologics Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Soft Tissue Biologics Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Soft Tissue Biologics Sales, 2017-2028
  6.8.3 Turkey Soft Tissue Biologics Market Size, 2017-2028
  6.8.4 Israel Soft Tissue Biologics Market Size, 2017-2028
  6.8.5 Saudi Arabia Soft Tissue Biologics Market Size, 2017-2028
  6.8.6 UAE Soft Tissue Biologics Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 AlloSource
  7.1.1 AlloSource Corporate Summary
  7.1.2 AlloSource Business Overview
  7.1.3 AlloSource Soft Tissue Biologics Major Product Offerings
  7.1.4 AlloSource Soft Tissue Biologics Sales and Revenue in Global (2017-2022)
  7.1.5 AlloSource Key News
7.2 Arthrex
  7.2.1 Arthrex Corporate Summary
  7.2.2 Arthrex Business Overview
  7.2.3 Arthrex Soft Tissue Biologics Major Product Offerings
  7.2.4 Arthrex Soft Tissue Biologics Sales and Revenue in Global (2017-2022)
  7.2.5 Arthrex Key News
7.3 ConMed
  7.3.1 ConMed Corporate Summary
  7.3.2 ConMed Business Overview
  7.3.3 ConMed Soft Tissue Biologics Major Product Offerings
  7.3.4 ConMed Soft Tissue Biologics Sales and Revenue in Global (2017-2022)
  7.3.5 ConMed Key News
7.4 LifeNet Health
  7.4.1 LifeNet Health Corporate Summary
  7.4.2 LifeNet Health Business Overview
  7.4.3 LifeNet Health Soft Tissue Biologics Major Product Offerings
  7.4.4 LifeNet Health Soft Tissue Biologics Sales and Revenue in Global (2017-2022)
  7.4.5 LifeNet Health Key News
7.5 Smith & Nephew
  7.5.1 Smith & Nephew Corporate Summary
  7.5.2 Smith & Nephew Business Overview
  7.5.3 Smith & Nephew Soft Tissue Biologics Major Product Offerings
  7.5.4 Smith & Nephew Soft Tissue Biologics Sales and Revenue in Global (2017-2022)
  7.5.5 Smith & Nephew Key News
7.6 Stryker
  7.6.1 Stryker Corporate Summary
  7.6.2 Stryker Business Overview
  7.6.3 Stryker Soft Tissue Biologics Major Product Offerings
  7.6.4 Stryker Soft Tissue Biologics Sales and Revenue in Global (2017-2022)
  7.6.5 Stryker Key News
7.7 Surgalign Spine Technologies
  7.7.1 Surgalign Spine Technologies Corporate Summary
  7.7.2 Surgalign Spine Technologies Business Overview
  7.7.3 Surgalign Spine Technologies Soft Tissue Biologics Major Product Offerings
  7.7.4 Surgalign Spine Technologies Soft Tissue Biologics Sales and Revenue in Global (2017-2022)
  7.7.5 Surgalign Spine Technologies Key News
7.8 Zimmer Biomet
  7.8.1 Zimmer Biomet Corporate Summary
  7.8.2 Zimmer Biomet Business Overview
  7.8.3 Zimmer Biomet Soft Tissue Biologics Major Product Offerings
  7.8.4 Zimmer Biomet Soft Tissue Biologics Sales and Revenue in Global (2017-2022)
  7.8.5 Zimmer Biomet Key News

8 GLOBAL SOFT TISSUE BIOLOGICS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Soft Tissue Biologics Production Capacity, 2017-2028
8.2 Soft Tissue Biologics Production Capacity of Key Manufacturers in Global Market
8.3 Global Soft Tissue Biologics Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 SOFT TISSUE BIOLOGICS SUPPLY CHAIN ANALYSIS

10.1 Soft Tissue Biologics Industry Value Chain
10.2 Soft Tissue Biologics Upstream Market
10.3 Soft Tissue Biologics Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Soft Tissue Biologics Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

LIST OF TABLES

Table 1. Key Players of Soft Tissue Biologics in Global Market
Table 2. Top Soft Tissue Biologics Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Soft Tissue Biologics Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Soft Tissue Biologics Revenue Share by Companies, 2017-2022
Table 5. Global Soft Tissue Biologics Sales by Companies, (K Units), 2017-2022
Table 6. Global Soft Tissue Biologics Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Soft Tissue Biologics Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Soft Tissue Biologics Product Type
Table 9. List of Global Tier 1 Soft Tissue Biologics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Soft Tissue Biologics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Soft Tissue Biologics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Soft Tissue Biologics Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Soft Tissue Biologics Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Soft Tissue Biologics Sales (K Units), 2017-2022
Table 15. By Type - Global Soft Tissue Biologics Sales (K Units), 2023-2028
Table 16. By Application – Global Soft Tissue Biologics Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Soft Tissue Biologics Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Soft Tissue Biologics Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Soft Tissue Biologics Sales (K Units), 2017-2022
Table 20. By Application - Global Soft Tissue Biologics Sales (K Units), 2023-2028
Table 21. By Region – Global Soft Tissue Biologics Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Soft Tissue Biologics Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Soft Tissue Biologics Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Soft Tissue Biologics Sales (K Units), 2017-2022
Table 25. By Region - Global Soft Tissue Biologics Sales (K Units), 2023-2028
Table 26. By Country - North America Soft Tissue Biologics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Soft Tissue Biologics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Soft Tissue Biologics Sales, (K Units), 2017-2022
Table 29. By Country - North America Soft Tissue Biologics Sales, (K Units), 2023-2028
Table 30. By Country - Europe Soft Tissue Biologics Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Soft Tissue Biologics Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Soft Tissue Biologics Sales, (K Units), 2017-2022
Table 33. By Country - Europe Soft Tissue Biologics Sales, (K Units), 2023-2028
Table 34. By Region - Asia Soft Tissue Biologics Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Soft Tissue Biologics Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Soft Tissue Biologics Sales, (K Units), 2017-2022
Table 37. By Region - Asia Soft Tissue Biologics Sales, (K Units), 2023-2028
Table 38. By Country - South America Soft Tissue Biologics Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Soft Tissue Biologics Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Soft Tissue Biologics Sales, (K Units), 2017-2022
Table 41. By Country - South America Soft Tissue Biologics Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Soft Tissue Biologics Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Soft Tissue Biologics Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Soft Tissue Biologics Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Soft Tissue Biologics Sales, (K Units), 2023-2028
Table 46. AlloSource Corporate Summary
Table 47. AlloSource Soft Tissue Biologics Product Offerings
Table 48. AlloSource Soft Tissue Biologics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Arthrex Corporate Summary
Table 50. Arthrex Soft Tissue Biologics Product Offerings
Table 51. Arthrex Soft Tissue Biologics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. ConMed Corporate Summary
Table 53. ConMed Soft Tissue Biologics Product Offerings
Table 54. ConMed Soft Tissue Biologics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. LifeNet Health Corporate Summary
Table 56. LifeNet Health Soft Tissue Biologics Product Offerings
Table 57. LifeNet Health Soft Tissue Biologics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Smith & Nephew Corporate Summary
Table 59. Smith & Nephew Soft Tissue Biologics Product Offerings
Table 60. Smith & Nephew Soft Tissue Biologics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Stryker Corporate Summary
Table 62. Stryker Soft Tissue Biologics Product Offerings
Table 63. Stryker Soft Tissue Biologics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Surgalign Spine Technologies Corporate Summary
Table 65. Surgalign Spine Technologies Soft Tissue Biologics Product Offerings
Table 66. Surgalign Spine Technologies Soft Tissue Biologics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Zimmer Biomet Corporate Summary
Table 68. Zimmer Biomet Soft Tissue Biologics Product Offerings
Table 69. Zimmer Biomet Soft Tissue Biologics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Soft Tissue Biologics Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 71. Global Soft Tissue Biologics Capacity Market Share of Key Manufacturers, 2020-2022
Table 72. Global Soft Tissue Biologics Production by Region, 2017-2022 (K Units)
Table 73. Global Soft Tissue Biologics Production by Region, 2023-2028 (K Units)
Table 74. Soft Tissue Biologics Market Opportunities & Trends in Global Market
Table 75. Soft Tissue Biologics Market Drivers in Global Market
Table 76. Soft Tissue Biologics Market Restraints in Global Market
Table 77. Soft Tissue Biologics Raw Materials
Table 78. Soft Tissue Biologics Raw Materials Suppliers in Global Market
Table 79. Typical Soft Tissue Biologics Downstream
Table 80. Soft Tissue Biologics Downstream Clients in Global Market
Table 81. Soft Tissue Biologics Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Soft Tissue Biologics Segment by Type
Figure 2. Soft Tissue Biologics Segment by Application
Figure 3. Global Soft Tissue Biologics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Soft Tissue Biologics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Soft Tissue Biologics Revenue, 2017-2028 (US$, Mn)
Figure 7. Soft Tissue Biologics Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Soft Tissue Biologics Revenue in 2021
Figure 9. By Type - Global Soft Tissue Biologics Sales Market Share, 2017-2028
Figure 10. By Type - Global Soft Tissue Biologics Revenue Market Share, 2017-2028
Figure 11. By Type - Global Soft Tissue Biologics Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Soft Tissue Biologics Sales Market Share, 2017-2028
Figure 13. By Application - Global Soft Tissue Biologics Revenue Market Share, 2017-2028
Figure 14. By Application - Global Soft Tissue Biologics Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Soft Tissue Biologics Sales Market Share, 2017-2028
Figure 16. By Region - Global Soft Tissue Biologics Revenue Market Share, 2017-2028
Figure 17. By Country - North America Soft Tissue Biologics Revenue Market Share, 2017-2028
Figure 18. By Country - North America Soft Tissue Biologics Sales Market Share, 2017-2028
Figure 19. US Soft Tissue Biologics Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Soft Tissue Biologics Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Soft Tissue Biologics Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Soft Tissue Biologics Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Soft Tissue Biologics Sales Market Share, 2017-2028
Figure 24. Germany Soft Tissue Biologics Revenue, (US$, Mn), 2017-2028
Figure 25. France Soft Tissue Biologics Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Soft Tissue Biologics Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Soft Tissue Biologics Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Soft Tissue Biologics Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Soft Tissue Biologics Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Soft Tissue Biologics Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Soft Tissue Biologics Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Soft Tissue Biologics Sales Market Share, 2017-2028
Figure 33. China Soft Tissue Biologics Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Soft Tissue Biologics Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Soft Tissue Biologics Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Soft Tissue Biologics Revenue, (US$, Mn), 2017-2028
Figure 37. India Soft Tissue Biologics Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Soft Tissue Biologics Revenue Market Share, 2017-2028
Figure 39. By Country - South America Soft Tissue Biologics Sales Market Share, 2017-2028
Figure 40. Brazil Soft Tissue Biologics Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Soft Tissue Biologics Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Soft Tissue Biologics Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Soft Tissue Biologics Sales Market Share, 2017-2028
Figure 44. Turkey Soft Tissue Biologics Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Soft Tissue Biologics Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Soft Tissue Biologics Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Soft Tissue Biologics Revenue, (US$, Mn), 2017-2028
Figure 48. Global Soft Tissue Biologics Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Soft Tissue Biologics by Region, 2021 VS 2028
Figure 50. Soft Tissue Biologics Industry Value Chain
Figure 51. Marketing Channels


More Publications